EFDID: 557765EFD: View Filing

Issuer: CollPlant Biotechnologies Ltd (0001631487) - D

Accession: 0001213900-25-050961 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001631487
  • Entity Name:
    CollPlant Biotechnologies Ltd
  • Entity Type:
    Corporation
  • Jurisdiction:
    ISRAEL
  • Year of Inc:
    Over 5 years ago
  • Address:
    4 OPPENHEIMER, WEIZMANN SCIENCE PARK
    REHOVOT, L3 7670104
  • Persons:
    Related Persons 12
    Yehiel Tal
    Executive Officer, Director 
    Chief Executive Officer and Director
    Eran Rotem
    Executive Officer 
    Deputy Chief Executive Officer and Chief Financial Officer
    Oren Fahimipoor
    Executive Officer 
    Vice President, Operations
    Philippe Bensimon
    Executive Officer 
    Vice President, Regulatory Affairs and Quality Assurance
    Elana Gazal
    Executive Officer 
    Vice President, Research and Development
    Hadas Dreiher Horowitz
    Executive Officer 
    Vice President, Human Resources
    Roger Dreiher Pomerantz
    Director
    Abraham Havron
    Director
    Elan Penn
    Director
    Joseph Zarzewsky
    Director
    Hugh Evans
    Director
    Alisa Lask
    Director
EDGAR: Offering Information
  • Accession Date:
    06/04/2025
  • First Sale Date:
    05/29/2025
  • Offering Amount:
    $3,870,006
  • Amount Sold:
    $3,870,006
  • Exemptions:
    Rule 506
  • Security Type(s):
  • Sales Clarification:
    The warrants and shares underlying the warrants, were issued in connection with an offering of (i) 1,200,002 ordinary shares issued in a registered direct offering, and (ii) unregistered warrants to purchase 1,272,002 ordinary shares.
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
H.C. Wainwright & Co. LLC 000000375 None None CA, FL, IL, NY
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
CollPlant Biotechnologies Ltd/s/ Eran RotemEran RotemDeputy Chief Executive Officer and Chief Financial Officer2025-06-04